Dulles Greenway litigation update
Open PDF
| Stock | Atlas Arteria (ALX.ASX) |
|---|---|
| Release Time | 29 Jun 2026, 9:26 a.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
Atlas Arteria Update on Dulles Greenway Litigation
Key Points
- US District Court dismissed the 2024 Dulles Greenway rate case federal litigation.
- TRIP II is considering whether to appeal the decision.
- Positive legislative reforms have streamlined the regulatory process.
Full Summary
Atlas Arteria Limited (ASX:ALX) announced that Toll Road Investors Partnership II, L.P. (TRIP II) received notification that the US District Court for the Eastern District of Virginia dismissed the 2024 Dulles Greenway rate case federal litigation. TRIP II is currently reviewing the decision and considering whether to appeal. The dismissal follows positive legislative reforms enacted earlier this year that streamlined the regulatory process by allowing up to two-year toll applications and establishing defined timelines for SCC decisions. Atlas Arteria continues to pursue options that create shared value and engages constructively with the Commonwealth of Virginia, local governments, and the community.
Sign in to get more information about the company, including guidance changes and other insights.
Sign In